Applications of PET imaging with the proliferation marker [18F]-FLT - Wikidata - wikimedia - TriplyDB

Applications of PET imaging with the proliferation marker [18F]-FLT

Applications of PET imaging with the proliferation marker [18F]-FLT

http://www.wikidata.org/entity/Q28083952

about

Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging Preclinical Applications of 3'-Deoxy-3'-[18F]Fluorothymidine in Oncology - A Systematic Review.Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined 18F-FDG and 18F-FLT PET/CT imaging.

P2860

Q26796223-055B11DA-DA80-41B3-99F8-9464F97E962C Q38775709-0C715430-7F23-4675-A0EF-F91E7E2BD6DD Q52597352-7AFF90AA-36E1-4CFB-B491-13AC97349519

P2860

Applications of PET imaging with the proliferation marker [18F]-FLT

http://www.wikidata.org/entity/Q28083952

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Applications of PET imaging with the proliferation marker [18F]-FLT

@ast

Applications of PET imaging with the proliferation marker [18F]-FLT

@en

Applications of PET imaging with the proliferation marker [18F]-FLT

@nl

type

label

Applications of PET imaging with the proliferation marker [18F]-FLT

@ast

Applications of PET imaging with the proliferation marker [18F]-FLT

@en

Applications of PET imaging with the proliferation marker [18F]-FLT

@nl

prefLabel

Applications of PET imaging with the proliferation marker [18F]-FLT

@ast

Applications of PET imaging with the proliferation marker [18F]-FLT

@en

Applications of PET imaging with the proliferation marker [18F]-FLT

@nl

P1433

Q28083952-B2E11C6D-7F0B-41F5-B8E6-89F9310169C2

P1476

Q28083952-5AD713CB-C251-4EE7-8952-EA07C09677EC

P2093

Q28083952-277D1129-8318-4424-A43E-81408B8A9A43

Q28083952-41B78F83-E568-48CF-BF6B-8EA5F6A9E4B1

Q28083952-7516A646-8A80-4EAC-BF44-D47244A69D29

Q28083952-87E1D396-0535-4C0A-A781-C4F6C8A0FCCA

Q28083952-95FBEEF0-9FF7-4248-9466-623A3831B11F

Q28083952-A8B937E8-7B70-4B1B-9944-A820A367AC47

Q28083952-B4CD53F8-E919-4E31-80A8-F952A6316A01

Q28083952-BFFF9029-A0BB-439F-9366-74660524FC6E

Q28083952-D169C440-C20A-4033-807C-46A847CCD5FB

Q28083952-E673A736-AB29-4D2A-92C3-054DDFE58BB6

P2860

Q28083952-057DB5A1-F329-4A51-AA6A-A76D444ABEB8

Q28083952-11E6B50E-FEB0-4A49-A89C-41325555A202

Q28083952-1B3940CB-2429-436B-8E39-EA1FA66AEF02

Q28083952-1EB81E65-8368-461B-8520-050E5298E5C7

Q28083952-2E2A8CB9-09FB-40EC-81F5-DA47A75D9A9C

Q28083952-2F1F45A7-1831-42A4-926C-EC4255A3ADE6

Q28083952-3A784D75-58F0-4E2A-81E9-E9F46951D26C

Q28083952-4153F05D-FC86-420F-917C-ADB54A0DF56B

Q28083952-440001AF-C865-4B0C-A27C-58BEF8F73989

Q28083952-44A5C8ED-F3F1-41E7-9391-D90B943CD7E4

P304

Q28083952-90DCA8CF-3E89-46FC-9112-6AFA2B261ABA

P31

Q28083952-A4C171B3-CACA-4FF5-9527-9535A6C213FB

P407

Q28083952-26BB21BF-5B1F-4529-B6AF-5ED6BB8478F6

P433

Q28083952-87530328-00F0-484B-8A8B-14708C04CF41

P478

Q28083952-FD9449EF-F467-4CCA-82E2-61E51E4C0025

P577

Q28083952-3CAC90D3-4C50-462E-9976-CA1A59FC905F

P698

Q28083952-42773239-5B93-493C-96A8-C14C5BD3F02D

P932

Q28083952-FD578CC4-78FE-434C-8777-D639AD802140

P1433

The Quarterly Journal of Nuclear Medicine and Molecular Imaging

P1476

Applications of PET imaging with the proliferation marker [18F]-FLT

@en

P2093

Armstrong JO

http://www.w3.org/2001/XMLSchema#string

Fink JR

http://www.w3.org/2001/XMLSchema#string

Friesen A

http://www.w3.org/2001/XMLSchema#string

Krohn KA

http://www.w3.org/2001/XMLSchema#string

Link JM

http://www.w3.org/2001/XMLSchema#string

Muzi M

http://www.w3.org/2001/XMLSchema#string

Peck M

http://www.w3.org/2001/XMLSchema#string

Pollack HA

http://www.w3.org/2001/XMLSchema#string

Shankland EG

http://www.w3.org/2001/XMLSchema#string

Shoner SC

http://www.w3.org/2001/XMLSchema#string

P2860

Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides

Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer.

Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with erlotinib.

Pemetrexed induced thymidylate synthase inhibition in non-small cell lung cancer patients: a pilot study with 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography.

The role of nucleoside/nucleotide transport and metabolism in the uptake and retention of 3'-fluoro-3'-deoxythymidine in human B-lymphoblast cells.

Different modes of transport for 3H-thymidine, 3H-FLT, and 3H-FMAU in proliferating and nonproliferating human tumor cells.

Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma.

NCI-sponsored trial for the evaluation of safety and preliminary efficacy of 3'-deoxy-3'-[18F]fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: preliminary efficacy studies

[(18)F]FLT: an imaging biomarker of tumour proliferation for assessment of tumour response to treatment.

Correlation between Ki-67 immunohistochemistry and 18F-fluorothymidine uptake in patients with cancer: A systematic review and meta-analysis.

P304

95-104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25737423

http://www.w3.org/2001/XMLSchema#string

P932

4415691

http://www.w3.org/2001/XMLSchema#string